Previous Close | 161.3 |
1-Year Change | 44.2% |
6-Months Change | -9.69% |
3-Months Change | -11.9% |
Moving Avg (50d) | 166.73 |
Moving Avg (200d) | 176.9 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 4.55B |
Beta (3-Years) | 1.28 |
Revenue Growth (ttm) | % |
Net Profit Margin (ttm) | -348.43% |
Return On Assets (ttm) | -3.77% |
EPS (ttm) | -1.47 |
PE Ratio (ttm) | -109.73 |
Dividend Yield | % |
Asset Description: | Krystal Biotech, Inc. |
Predicted Direction: | Buy |
Signal Strength: | Neutral |
Forecast Date: | 2025-01-21 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
158.074 | 153.235 | 150.009 | 145.17 | 137.105 | 129.04 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.